|

Vericiguat tablet Clinical Trials

2 actively recruiting trials across 1 location

Also known as: MK-1242

Pipeline

Phase 1: 1Phase 2/3: 1

Top Sponsors

  • Merck Sharp & Dohme LLC1
  • Khawaja Danish Ali1

Indications

  • Heart Disease2
  • Decompensated Heart Failure1
  • Left Ventricular Systolic Dysfunction1
  • Heart Failure1

Other1 trial

Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Phase 1

Los Angeles, California1 trial

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 0002)

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.